| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-08 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 3e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 5e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.26 | 5e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |